These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21390140)

  • 41. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors.
    Söderström A; Norkrans G; Conradi N; Krantz M; Horal P; Lindh M
    J Pediatr Gastroenterol Nutr; 2002 Oct; 35(4):487-94. PubMed ID: 12394372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution of hepatitis B virus genotypes: phylogenetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, Eastern India.
    Banerjee A; Datta S; Chandra PK; Roychowdhury S; Panda CK; Chakravarty R
    World J Gastroenterol; 2006 Oct; 12(37):5964-71. PubMed ID: 17009394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
    Liu CJ; Jeng YM; Chen CL; Cheng HR; Chen PJ; Chen TC; Liu CH; Lai MY; Chen DS; Kao JH
    J Infect Dis; 2009 Mar; 199(5):742-9. PubMed ID: 19199543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Viral factors influencing histological changes of HBeAg-negative chronic hepatitis B patients with persistently normal serum ALT levels].
    Yang YH; Xie Q; Wang H; Zhou HJ; Gui HL; Cai W; Guo SM; Yu H; Guo Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):434-9. PubMed ID: 19567022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
    Yang HC; Chen CL; Shen YC; Peng CY; Liu CJ; Tseng TC; Su TH; Chuang WL; Yu ML; Dai CY; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2013 Mar; 57(3):934-43. PubMed ID: 23112104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.
    Wang XL; Ren JP; Wang XQ; Wang XH; Yang SF; Xiong Y
    World J Gastroenterol; 2016 Mar; 22(11):3268-74. PubMed ID: 27004005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
    Sonneveld MJ; Rijckborst V; Zeuzem S; Heathcote EJ; Simon K; Senturk H; Pas SD; Hansen BE; Janssen HL
    Hepatology; 2012 Jul; 56(1):67-75. PubMed ID: 22307831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
    Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
    World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.
    Tanaka Y; Mukaide M; Orito E; Yuen MF; Ito K; Kurbanov F; Sugauchi F; Asahina Y; Izumi N; Kato M; Lai CL; Ueda R; Mizokami M
    J Hepatol; 2006 Nov; 45(5):646-53. PubMed ID: 16935384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.
    Tseng TC; Yu ML; Liu CJ; Lin CL; Huang YW; Hsu CS; Liu CH; Kuo SF; Pan CJ; Yang SS; Su CW; Chen PJ; Chen DS; Kao JH
    Antivir Ther; 2011; 16(5):629-37. PubMed ID: 21817184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
    Shinkai N; Tanaka Y; Ito K; Mukaide M; Hasegawa I; Asahina Y; Izumi N; Yatsuhashi H; Orito E; Joh T; Mizokami M
    J Clin Microbiol; 2007 Oct; 45(10):3191-7. PubMed ID: 17652471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B.
    Suzuki F; Tsubota A; Arase Y; Suzuki Y; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Takagi K; Kumada H
    J Med Virol; 2003 Jul; 70(3):355-60. PubMed ID: 12766997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients.
    Chen CH; Lee CM; Hung CH; Wang JH; Hu TH; Changchien CS; Lu SN
    J Gastroenterol Hepatol; 2011 Mar; 26(3):461-8. PubMed ID: 21332543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
    Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
    J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
    Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
    Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predominance of precore mutations and clinical significance of basal core promoter mutations in chronic hepatitis B virus infection in Indonesia.
    Juniastuti ; Utsumi T; Aksono EB; Yano Y; Soetjipto ; Hayashi Y; Hotta H; Rantam FA; Kusumobroto HO; Lusida MI
    Biomed Rep; 2013 Jul; 1(4):522-528. PubMed ID: 24648979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.
    Yan LB; Zhu X; Bai L; Tang XQ; Du LY; Chen EQ; Liang LB; Tang H
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):296-302. PubMed ID: 27988305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Genetic variation and typing of hepatitis B virus in patients with chronic hepatitis B negative for HBeAg].
    Su R; Luo N; Yang Y; Zhuang J; Huang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1804-7. PubMed ID: 23268415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
    Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
    Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.